Can aromatherapy and brain games keep seniors safe at home?
NCT ID NCT02288221
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a home system that uses aromatherapy, music, and brain-training games to help older adults with mild memory issues stay safe and independent. Only 4 people took part before the study was stopped early. The goal was to see if seniors would use and enjoy these non-drug therapies.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- non-pharmacological home interventions (aromatherapy, music therapy, cognitive games)
- What this could lead to
- If it worked, this could point toward simple, drug-free ways to help older adults stay safe and independent at home.
- What could go wrong
- The trial was terminated early with only 4 participants, so no reliable conclusions can be drawn. The approach is still very experimental.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
4 people
The number who actually took part.
- Started
-
Jun 2015
- Finished
-
Jul 2017
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
60 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Male or female age ≥ 60 years with memory complaint * Score at the Mini Mental Test (MMSE) ≥ 26. * Score at the Clinical Dementia Rating Scale (CDR) ≤ 0.5. Exclusion Criteria: * Sensory defect (visual or olfactory) preventing the patient to perfectly meet therapeutic solutions. * Prescription new psychotropic medication (hypnotic, anxiolytic, antidepressant, antipsychotic) in the week preceding the assessment. * Subject epileptic. * Subject vulnerable
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Cognitive deterioration are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institut Claude Pompidou
Nice, 06000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Brain scans and genes may unlock early Alzheimer's detection
- Could a daily mushroom help shield aging brains?
- Could chatting with AI keep aging brains sharp?
- Simple blood test may replace spinal taps for Alzheimer's diagnosis
- Aggressive blood pressure control may fight Alzheimer's in the brain
- Can a friendly video chat lift depression in older adults?